News

Northwest Bio (OTCQB:NWBO) has some important news – just today, they provided a clear timeline for submitting an application for…

While the direct market impact of geopolitical conflict is typically short-lived, the macro impacts can often linger. The key macro…

I have not failed. I’ve just found 10,000 ways that won’t work.”― Thomas A. Edison Today, we are putting Mersana…

Investment thesis Our current investment thesis is: CBIZ currently has a strong foundation from which to achieve MSD/HSD growth into…

European regulator Thierry Breton shared a stern letter to TikTok CEO Shou Zi Chew on Thursday, claiming his office has…

Elon Musk’s X broke the law in firing an employee who criticized management’s return-to-work policy, the National Labor Relations Board…

The WisdomTree U.S. Efficient Core Fund (NYSEARCA:NTSX) is an interest asset allocation fund that effectively provides 1.5x leveraged returns to…

By Ed Moya US This week Wall Street will learn how quickly the US consumer is weakening and if the…

Intro Relmada Therapeutics (NASDAQ:RLMD) is advancing its NMDA antagonist, REL-1017 (esmethadone), as a novel antidepressant for the treatment of major…

Mind Medicine (NASDAQ:MNMD) has been making great progress lately in advancing the use of a drug in its pipeline known…